1410075-23-8

Basic information

• Product Name: 2-(benzhydrylsulfinyl)-N-((tetrahydrofuran-2-yl)methyl)acetamide
• Synonyms: 2-(benzhydrylsulfinyl)-N-((tetrahydrofuran-2-yl)methyl)acetamide
• CAS NO: 1410075-23-8
• Molecular Weight: 357.474
• Mol File: 1410075-23-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(benzhydrylsulfinyl)-N-((tetrahydrofuran-2-yl)methyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(benzhydrylsulfinyl)-N-((tetrahydrofuran-2-yl)methyl)acetamide(1410075-23-8)
• EPA Substance Registry System: 2-(benzhydrylsulfinyl)-N-((tetrahydrofuran-2-yl)methyl)acetamide(1410075-23-8)

Safety Data

• Hazardous Substances Data: 1410075-23-8(Hazardous Substances Data)

Upstream product

• 4795-29-3 TETRAHYDROFURFURYLAMINE 
• 63547-24-0 modafinil acid 
• 63547-22-8 (benzhydrylthio)acetic acid 
• 91-01-0 1,1-Diphenylmethanol 
• 118286-19-4 (diphenylmethyl)(ethyl acetate)sulfoxide 

Relevant articles and documents

COMPOSITION OF THE TREATMENT OF VASCULAR DISEASES OR KCa3.1 CHANNEL-MEDIATED DISEASES COMPRISING MODAFINIL OR DERIVATIVES THEREOF

The present invention relates to modafinil or derivatives thereof as a medicine for the treatment of vascular diseases or KCa3.1 channel (Ca activated K channel) mediated diseases and a novel use of the same. More specifically, the present invention relates to a pharmaceutical composition for the prevention or treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or a derivative of modafinil, or pharmaceutically acceptable salts thereof which relax blood vessels and inhibit KCa3.1 channel currents by increasing intracellular cAMP, a method for treating vascular diseases or KCa3.1 channel-mediated diseases using the composition and a health functional food composition for the prevention or improvement of vascular diseases or the KCa3.1 channel-mediated diseases comprising modafinil or a modafinil derivative compound, or sitologically acceptable salts thereof.